PMGC HOLDINGS INC. Number of Reportable Segments
PMGC HOLDINGS INC. (ELAB) reported Number of Reportable Segments of 3 segments for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes
us-gaap:NumberOfReportableSegments · last filed 2026-08-14
- PMGC HOLDINGS INC. number of reportable segments for fiscal 2024 was 1.00 Segment.
Segment
| Period end | Number of Reportable Segments 12 month |
|---|---|
| 2024-12-31 | 1.00 Segment 10-K · filed 2025-03-28 |
segments
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 3.00 segments 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | 3.00 segments 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | 3.00 segments 10-K · filed 2026-03-30 | |||
| 2025-09-30 | 3.00 segments 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |